• This record comes from PubMed

Huprine Y - Tryptophan heterodimers with potential implication to Alzheimer's disease treatment

. 2021 Jul 01 ; 43 () : 128100. [epub] 20210510

Language English Country Great Britain, England Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't

Links

PubMed 33984470
DOI 10.1016/j.bmcl.2021.128100
PII: S0960-894X(21)00326-7
Knihovny.cz E-resources

The search for novel and effective therapeutics for Alzheimer's disease (AD) is the main quest that remains to be resolved. The goal is to find a disease-modifying agent able to confront the multifactorial nature of the disease positively. Herewith, a family of huprineY-tryptophan heterodimers was prepared, resulting in inhibition of cholinesterase and neuronal nitric oxide synthase enzymes, with effect against amyloid-beta (Aβ) and potential ability to cross the blood-brain barrier. Their cholinesterase pattern of behavior was inspected using kinetic analysis in tandem with docking studies. These heterodimers exhibited a promising pharmacological profile with strong implication in AD.

References provided by Crossref.org

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...